Prudent Man Advisors LLC Lowers Position in SPDR S&P Biotech ETF $XBI

Prudent Man Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 44.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,783 shares of the exchange traded fund’s stock after selling 6,245 shares during the period. Prudent Man Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $780,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Capital A Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $26,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $31,000. Twin Peaks Wealth Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $32,000. Davis Capital Management purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $35,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000.

SPDR S&P Biotech ETF Stock Down 0.8%

Shares of NYSEARCA:XBI opened at $126.38 on Thursday. The firm has a 50 day moving average of $125.45 and a 200 day moving average of $114.72. The company has a market capitalization of $8.44 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.